These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 9817599)
21. A novel, cell-type-specific mechanism for estrogen receptor-mediated gene activation in the absence of an estrogen-responsive element. Sukovich DA; Mukherjee R; Benfield PA Mol Cell Biol; 1994 Nov; 14(11):7134-43. PubMed ID: 7935428 [TBL] [Abstract][Full Text] [Related]
22. Identification of the sequences within the human complement 3 promoter required for estrogen responsiveness provides insight into the mechanism of tamoxifen mixed agonist activity. Fan JD; Wagner BL; McDonnell DP Mol Endocrinol; 1996 Dec; 10(12):1605-16. PubMed ID: 8961270 [TBL] [Abstract][Full Text] [Related]
23. The quinone reductase gene: a unique estrogen receptor-regulated gene that is activated by antiestrogens. Montano MM; Katzenellenbogen BS Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2581-6. PubMed ID: 9122238 [TBL] [Abstract][Full Text] [Related]
24. Activation of transcriptional activities of AP1 and SRE by a novel zinc finger protein ZNF445. Luo K; Yuan J; Shan Y; Li J; Xu M; Cui Y; Tang W; Wan B; Zhang N; Wu Y; Yu L Gene; 2006 Feb; 367():89-100. PubMed ID: 16368201 [TBL] [Abstract][Full Text] [Related]
25. Promoter analysis of mouse estrogen-responsive finger protein (efp) gene: mouse efp promoter contains an E-box that is also conserved in human. Ikeda K; Inoue S; Orimo A; Tsutsumi K; Muramatsu M Gene; 1998 Aug; 216(1):155-62. PubMed ID: 9714786 [TBL] [Abstract][Full Text] [Related]
26. Specific mutations in the estrogen receptor change the properties of antiestrogens to full agonists. Mahfoudi A; Roulet E; Dauvois S; Parker MG; Wahli W Proc Natl Acad Sci U S A; 1995 May; 92(10):4206-10. PubMed ID: 7753783 [TBL] [Abstract][Full Text] [Related]
27. Synergistic activation of estrogen receptor-mediated transcription by estradiol and protein kinase activators. Cho H; Katzenellenbogen BS Mol Endocrinol; 1993 Mar; 7(3):441-52. PubMed ID: 7683375 [TBL] [Abstract][Full Text] [Related]
28. Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors. Read LD; Greene GL; Katzenellenbogen BS Mol Endocrinol; 1989 Feb; 3(2):295-304. PubMed ID: 2785242 [TBL] [Abstract][Full Text] [Related]
29. Characterization of an early growth response gene, which encodes a zinc finger transcription factor, potentially involved in cell cycle regulation. Blok LJ; Grossmann ME; Perry JE; Tindall DJ Mol Endocrinol; 1995 Nov; 9(11):1610-20. PubMed ID: 8584037 [TBL] [Abstract][Full Text] [Related]
30. Cloning and characterization of a novel zinc finger protein (MDZF) that is associated with monocytic differentiation of acute promyelocytic leukemia cells. Yuan Z; Huang X; Zhang W; Zhang M; Wan T; Cao X J Cancer Res Clin Oncol; 2001 Nov; 127(11):659-67. PubMed ID: 11710595 [TBL] [Abstract][Full Text] [Related]
31. Identification of a negative regulatory surface within estrogen receptor alpha provides evidence in support of a role for corepressors in regulating cellular responses to agonists and antagonists. Huang HJ; Norris JD; McDonnell DP Mol Endocrinol; 2002 Aug; 16(8):1778-92. PubMed ID: 12145334 [TBL] [Abstract][Full Text] [Related]
32. Molecular cloning of rat efp: expression and regulation in primary osteoblasts. Inoue S; Urano T; Ogawa S; Saito T; Orimo A; Hosoi T; Ouchi Y; Muramatsu M Biochem Biophys Res Commun; 1999 Aug; 261(2):412-8. PubMed ID: 10425199 [TBL] [Abstract][Full Text] [Related]
33. Cloning and characterization of ZNF189, a novel human Krüppel-like zinc finger gene localized to chromosome 9q22-q31. Odeberg J; Røsok O; Gudmundsson GH; Ahmadian A; Roshani L; Williams C; Larsson C; Pontén F; Uhlén M; Asheim HC; Lundeberg J Genomics; 1998 Jun; 50(2):213-21. PubMed ID: 9653648 [TBL] [Abstract][Full Text] [Related]
34. Estrogen-inducible derivatives of hepatocyte nuclear factor-4, hepatocyte nuclear factor-3 and liver factor B1 are differently affected by pure and partial antiestrogens. Drewes T; Clairmont A; Klein-Hitpass L; Ryffel GU Eur J Biochem; 1994 Oct; 225(1):441-8. PubMed ID: 7925467 [TBL] [Abstract][Full Text] [Related]
35. Intergenic splicing of MDS1 and EVI1 occurs in normal tissues as well as in myeloid leukemia and produces a new member of the PR domain family. Fears S; Mathieu C; Zeleznik-Le N; Huang S; Rowley JD; Nucifora G Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1642-7. PubMed ID: 8643684 [TBL] [Abstract][Full Text] [Related]
36. Differential recruitment of coregulator proteins steroid receptor coactivator-1 and silencing mediator for retinoid and thyroid receptors to the estrogen receptor-estrogen response element by beta-estradiol and 4-hydroxytamoxifen in human breast cancer. Fleming FJ; Hill AD; McDermott EW; O'Higgins NJ; Young LS J Clin Endocrinol Metab; 2004 Jan; 89(1):375-83. PubMed ID: 14715875 [TBL] [Abstract][Full Text] [Related]
37. PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer. Ghosh MG; Thompson DA; Weigel RJ Cancer Res; 2000 Nov; 60(22):6367-75. PubMed ID: 11103799 [TBL] [Abstract][Full Text] [Related]
38. A novel estrogen receptor variant mRNA lacking exons 4 to 6 in breast carcinoma. Chan CM; Dowsett M J Steroid Biochem Mol Biol; 1997 Aug; 62(5-6):419-30. PubMed ID: 9449245 [TBL] [Abstract][Full Text] [Related]
39. The F domain of estrogen receptor α is involved in species-specific, tamoxifen-mediated transactivation. Arao Y; Korach KS J Biol Chem; 2018 Jun; 293(22):8495-8507. PubMed ID: 29632071 [TBL] [Abstract][Full Text] [Related]
40. Estrogen receptor domains E and F: role in dimerization and interaction with coactivator RIP-140. Peters GA; Khan SA Mol Endocrinol; 1999 Feb; 13(2):286-96. PubMed ID: 9973258 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]